PTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Prescient Therapeutics Ltd

Watchlist Manager

Watchlist

Price on Oct 14: 0.065 AUD

Market Cap: AU$68.3m

Prices of ASX stocks are not being updated. The latest PTX price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.

	Prescient Therapeutics Ltd ASX:PTX	AU
	Pitney Bowes Inc NYSE:PBI	US
I	i-Components Co Ltd KOSDAQ:059100	KR
L	Lloyds Banking Group PLC OTC:LLDTF	UK
	Absa Group Ltd F:AU6	ZA
R	Raspadskaya PAO MOEX:RASP	RU
	Citizens Inc NYSE:CIA	US
	Midland Exploration Inc OTC:MIDLF	CA

Profitability Summary

Prescient Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-5 055%

Negative 3Y Average Operating Margin

-6 193%

Declining Operating Margin

-1 538% > -5 055%

Negative Net Margin

-5 056%

Negative 3Y Average Net Margin

-6 232%

Declining Net Margin

-1 526% > -5 056%

Negative Free Cash Flow Margin

-5 216%

Negative 3Y Average Free Cash Flow Margin

-5 906%

Declining Free Cash Flow Margin

-1 349% > -5 216%

Negative ROE

-55%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-147%

ROIC is Increasing

-156% > -139%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.